ArticleScientific reports2025
Mapping of the Antinuclear Autoantibodies in Sudanese patients infected with Human Immunodeficiency Virus after HAART receiving: A cross-sectional study.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
It is important to highlight that infection with the human immunodeficiency virus (HIV) may trigger chronic inflammation in people living with HIV/AIDS (PLWHA), impacting to the key immune cells such B and T lymphocytes, leading to development of autoantibodies which might be potential to developed autoimmune phenomenon. This study represent the first investigation in Sudan designed to evaluate and determine the prevalence of Antinuclear autoantibody (ANA) among people living with HIV/AIDS by systematically charaterizing ANA staining patterns; distribution, frequency and their correlation with estimated endpoint titers and interplay of age -sex specific ANA patterns in the context of HIV infection post antiretroviral therapy era. Using Serum samples of one hundred and sixteen (116) HIV-infected patients admitted to two major Voluntary Testing and Counseling (VTC), of the HIV clinical centers at the Military Hospital and Bahri Hospital in Khartoum, Sudan, have been assessed for ANA screening. A total of 116 HIV confirmed cases, were screened for ANA autoantibodies using HEp-2 cell indirect immunofluorescent technique. out of 116 85/116 (73.3%) were showed positivity for ANA. the proportion of ANA positivity among the male group was higher than the female group, 49/65 (75.4%) and 36/51 (70.6%), respectively, but there are no significant statistical differences (p = 0.7). Interestingly, a high proportion of positivity for ANA were found in the older subject groups (aged 42-56 years and > 57 years), with rates of 80% for each. Furthermore, our study also showed that the predominant ANA patterns were nuclear fine-speckled (AC-4, 56.5%) followed by cytoplasmic fine granules (AC-20, 24.7%). This study suggests that HIV might induced chronic inflammation and trigger the production of autoantibodies with variable specificities, needing further studies to better understand the role of HIV-driven chronic inflammation in shaping autoimmune serological profiles in these patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.